![](https://investorshub.advfn.com/uicon/563962.png?cb=1562358883)
Sunday, April 24, 2022 8:53:18 AM
Zhabilov, Dr. Harry
World renowned scientist, born in Sofia, Bulgaria and discover of TNP a nuclear non histone protein which has proven effective in the treatment of AIDS and Herpes, expired May 9, 2002 in South Pasadena, CA from complications of heart disease at age 63. Among his many other appointments and humanitarian awards for contributions to since, Dr. Zhabilov served as head of the Autoimmune Disease Research Laboratory at the National Institute of Antibiotics of Bulgaria from 1975 until his invitation to work in the Unites States. In 1995, Dr. Zhabilov cofounded Viral Genetics, Inc., a California corporation, focused on developing new breakthrough technology associate with TNP. Viral Genetics, Inc. has obtained patents in over 17 countries and has applied for approval of the sale of its technology by the State Drug Administration for the Peoples Republic of China and the Department of Health for the Republic of Mexico. Dr. Zhabilov is survived by his wife, two sons, daughter-in-law, and grandchild.
Published by Los Angeles Times on May 16, 2002.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM